Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$38K 68
2022
Q3
$38K Hold
100,000
0.02% 25
2022
Q2
$75K Sell
100,000
-200,000
-67% -$6.72M 0.03% 85
2022
Q1
$743K Buy
+300,000
New +$12.9M 0.19% 39
2021
Q4
Sell
-900,000
Closed -$2.39M 176
2021
Q3
$2.39M Sell
900,000
-200,000
-18% -$7.97M 0.69% 33
2021
Q2
$4.43M Sell
1,100,000
-300,000
-21% -$14M 1.3% 22
2021
Q1
$10.2M Buy
+1,400,000
New +$52.9M 2.7% 11

Other funds holding ADNT

Littlejohn & Co's ADNT Position: Q2 2022 in Review

Littlejohn & Co sold out of Adient (ADNT) in Q2 2022, closing a stake of 199,329 shares — an estimated $6.7M sold.

Littlejohn & Co first reported a position in ADNT in Q1 2021 and held it in 5 quarters. The position peaked at $31.5M in Q3 2021. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • Littlejohn & Co reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • Littlejohn & Co sold 199,329 Adient shares in Q2 2022, an estimated $6.7M.
  • Littlejohn & Co first reported a position in Adient in Q1 2021 and held it in 5 quarters.
  • Littlejohn & Co's Adient position peaked at $31.5M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Littlejohn & Co's 13F filing for Q2 2022, filed 8 Aug 2022.